VINC
Vincerx Pharma, Inc.
$0.0130
0.00%
No data for this timeframe.
Vol
Inst. Holders5 funds
Inst. Value$30.4K
Inst. Activity1 buys / 2 sells
Recent Activity
Inst.
CITADEL ADVISORS LLC — NEW
42,777 shares ($22.6K)
Inst.
VANGUARD GROUP INC — EXIT
0 shares ($0.00)
May 13, 2026
earnings_calendar
VINC Q1 2026 Earnings Scheduled — 2026-05-13
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 8, 2024 | Leerink Partners | MAINTAIN | Outperform → Outperform |
| Apr 9, 2024 | Cantor Fitzgerald | REITERATE | Overweight |
| Apr 1, 2024 | Cantor Fitzgerald | REITERATE | Overweight |
| Sep 7, 2023 | Cantor Fitzgerald | REITERATE | Overweight → Overweight |
| Nov 17, 2022 | Chardan Capital | MAINTAIN | Buy |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| CITADEL ADVISORS LLC | $22.6K | NEW |
| VANGUARD GROUP INC | $7.6K | EXIT |
| UBS Group AG | $75.00 | EXIT |
| MORGAN STANLEY | $54.00 | — |
| BANK OF AMERICA CORP | $8.00 | — |
5 institutional holders with $30.4K total value (57,353 shares) as of 2025-Q1. Top holders: CITADEL, VANGUARD, UBS. Net selling activity: 2 institutions trimmed/exited vs 1 added.
Top Institutional Holders — 2025-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | 42,777 | $22.6K | 74.6% | NEW |
| 2 | VANGUARD GROUP INC | 14,317 | $7.6K | 24.9% | EXIT -100.0% |
| 3 | UBS Group AG | 142 | $75.00 | 0.2% | EXIT -100.0% |
| 4 | MORGAN STANLEY | 102 | $54.00 | 0.2% | — |
| 5 | BANK OF AMERICA CORP /DE/ | 15 | $8.00 | 0.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | NEW | — | 42,777 | — | $22.6K | 2025-Q1 |
| VANGUARD GROUP INC | EXIT | 286,372 | 0 | -100.0% | $0.00 | 2025-Q1 |
| UBS Group AG | EXIT | 92,779 | 0 | -100.0% | $0.00 | 2025-Q1 |
| UBS Group AG | DOUBLED | 238 | 92,779 | +38882.8% | $24.4K | 2024-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 66,001 | 22,100 | -66.5% | $5.8K | 2024-Q4 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Oct 2024): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q 2025-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2025-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
7 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 6 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Oct 8, 2024 | Leerink Partners | MAINTAIN | Outperform | Outperform |
| Apr 9, 2024 | Cantor Fitzgerald | REITERATE | — | Overweight |
| Apr 1, 2024 | Cantor Fitzgerald | REITERATE | — | Overweight |
| Sep 7, 2023 | Cantor Fitzgerald | REITERATE | Overweight | Overweight |
| Nov 17, 2022 | Chardan Capital | MAINTAIN | — | Buy |
| Aug 12, 2022 | SVB Leerink | MAINTAIN | — | Outperform |
| Jun 8, 2022 | Cantor Fitzgerald | MAINTAIN | — | Overweight |
| Jun 7, 2022 | B. Riley Securities | MAINTAIN | — | Buy |
| Jun 7, 2022 | Chardan Capital | MAINTAIN | — | Buy |
| Jun 7, 2022 | SVB Leerink | MAINTAIN | — | Outperform |
| May 13, 2022 | Chardan Capital | MAINTAIN | — | Buy |
| May 13, 2022 | SVB Leerink | MAINTAIN | — | Outperform |
| Mar 30, 2022 | SVB Leerink | MAINTAIN | — | Outperform |
| Mar 30, 2022 | HC Wainwright & Co. | MAINTAIN | — | Buy |
| Jan 14, 2022 | HC Wainwright & Co. | INITIATE | — | Buy |
| Dec 23, 2021 | Cantor Fitzgerald | INITIATE | — | Overweight |
| Nov 1, 2021 | SVB Leerink | INITIATE | — | Outperform |
| Sep 13, 2021 | Laidlaw & Co. | INITIATE | — | Buy |
| Aug 25, 2021 | B. Riley Securities | INITIATE | — | Buy |
| Aug 13, 2021 | Chardan Capital | MAINTAIN | — | Buy |
| Jan 6, 2021 | Chardan Capital | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| May 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Apr 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Mar 1, 2025 | 3 | 4 | 1 | 0 | 0 | 88% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 13, 2026
earnings_calendar
VINC Q1 2026 Earnings Scheduled — 2026-05-13
Mar 25, 2026
earnings_calendar
VINC Q4 2025 Earnings After Market Close — 2026-03-25